Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANGOCIN Anti-Infekt N versus placebo for prophylaxis of recurrent uncomplicated cystitis
2013-004653-25Phase 3Completed
- Sponsor
- Repha
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Angocin Anti-Infekt N in cystitis (2 arms), sponsored by Repha. Primary endpoints: First symptomatic microbiologically confirmed recurrence during prophylaxis, Rate of first recurrences during prophylaxis and 1 more. Started Feb 2014; status: completed.
02
Drugs
Angocin Anti-Infekt N
03
Conditions
cystitis
Beyond the preview
Go deeper on 2013-004653-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004653-25.